Schedule 13G ownership disclosure

ReShape Lifesciences Inc.

Common Stock, $0.001 par value per share · CUSIP: 76090R408

Event date: 2025-06-09

Filing-level shares
235,000.00
Percent of class
9.85%
  • L1 Capital Global Opportunities Master Fund, Ltd.

    Shares: 235,000.00 · Class: 9.85%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001079973-25-001028
Form type
SCHEDULE 13G
Filer
L1 Capital Global Opportunities Master Fund, Ltd.
CIK
CIK 1702202
Filed
Jun 13, 2025
Reporting period
Jun 09, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub